These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23188436)

  • 81. Enhanced expression of EphrinB1 is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yin H; Lu C; Tang Y; Wang H; Wang H; Wang J
    Cancer Biomark; 2013; 13(4):261-7. PubMed ID: 24240587
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
    Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S
    Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Imaging differences in metaplastic and invasive ductal carcinomas of the breast.
    Yang WT; Hennessy B; Broglio K; Mills C; Sneige N; Davis WG; Valero V; Hunt KK; Gilcrease MZ
    AJR Am J Roentgenol; 2007 Dec; 189(6):1288-93. PubMed ID: 18029860
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway.
    Adjei EK; Owusu-Afriyie O; Awuah B; Stalsberg H
    Breast J; 2014; 20(3):308-11. PubMed ID: 24708149
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?
    Yepes MM; Romilly AP; Collado-Mesa F; Net JM; Kiszonas R; Arheart KL; Young D; Glück S
    Breast Cancer Res Treat; 2014 Nov; 148(1):117-23. PubMed ID: 25262341
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Analysis of the cytological features supporting the diagnosis of lobular breast cancer. Factors associated with equivocal diagnoses.
    Divani SN; Kardasis ND
    J BUON; 2015; 20(1):40-4. PubMed ID: 25778294
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Synchronous and Unilateral Breast Cancers(Invasive Lobular Carcinoma and Non-Invasive Ductal Carcinoma) - A Case Report].
    Sakurai K; Fujisaki S; Kubota H; Hara Y; Suzuki S; Adachi K; Tomita R; Enomoto K; Hirano T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):73-75. PubMed ID: 29362312
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Breast-specific gamma imaging: correlations with mammographic and clinicopathologic characteristics of breast cancer.
    Park JY; Yi SY; Park HJ; Kim MS; Kwon HJ; Park NH; Moon SY
    AJR Am J Roentgenol; 2014 Jul; 203(1):223-8. PubMed ID: 24951219
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer.
    Narita D; Raica M; Suciu C; Cîmpean A; Anghel A
    Folia Histochem Cytobiol; 2006; 44(3):165-72. PubMed ID: 16977795
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
    Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
    Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression of selected proteins in breast cancer brain metastases.
    Gojis O; Kubecova M; Rosina J; Vranova J; Celko M; Frajerova D; Zmrhal J; Zahumensky J; Bacova T; Baca V; Mandys V; Kucera E
    Folia Histochem Cytobiol; 2013; 51(3):213-8. PubMed ID: 24203627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MR imaging features of triple-negative breast cancers.
    Sung JS; Jochelson MS; Brennan S; Joo S; Wen YH; Moskowitz C; Zheng J; Dershaw DD; Morris EA
    Breast J; 2013; 19(6):643-9. PubMed ID: 24015869
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
    Sunami E; Shinozaki M; Sim MS; Nguyen SL; Vu AT; Giuliano AE; Hoon DS
    Breast Cancer Res; 2008; 10(3):R46. PubMed ID: 18485221
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.
    Ma H; Xu X; Ursin G; Simon MS; Marchbanks PA; Malone KE; Lu Y; McDonald JA; Folger SG; Weiss LK; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
    Cancer Med; 2015 Jul; 4(7):1122-35. PubMed ID: 25924995
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
    Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
    Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients.
    Zheng K; Tan JX; Li F; Wei YX; Yin XD; Su XL; Li HY; Liu QL; Ma BL; Ou JH; Li H; Yang SS; Jiang AM; Ni Q; Liu JL; Liu JP; Zheng H; Song ZJ; Wang L; He JJ; Zou TN; Jiang J; Ren GS
    Breast Cancer Res Treat; 2017 Nov; 166(2):569-582. PubMed ID: 28770448
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Correlation of clinicopathologic parameters and immunohistochemical features of triple-negative invasive lobular carcinoma.
    Harbhajanka A; Lamzabi I; Singh RI; Ghai R; Reddy VB; Bitterman P; Gattuso P
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):e18-26. PubMed ID: 25003839
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mammography and ultrasound features of triple-negative breast cancer.
    Kojima Y; Tsunoda H
    Breast Cancer; 2011 Jul; 18(3):146-51. PubMed ID: 20972742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.